The next board meeting for Vivos Therapeutics Inc is on 28 Mar 2025 for the purpose of Vivos Therapeutics Inc Fourth Quarter Earnings Results for 2024See details
Vivos Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of 10.1%, and profit growth estimate of 19.4% for FY24, based on top 2 analyst calls.